Valence 標誌
熱門
登入
Loading data for PDEX — first visit, this takes a few seconds.

加入自選清單

Pro-Dex Inc.

NasdaqCM: PDEX · 即時價格 · USD
63.84
-1.38 (-2.12%)
收盤價： Aug 26, 2026, 3:59 PM

股價、關鍵數字和最新消息，都在這一頁。

Pro-Dex Inc.（PDEX）股價、分析與資料

-2.12%
買價64.5
市值203.83M
營收 (ttm)74.64M
淨利（ttm）12M
0.05
3.55
17.98
30.99
P/B (ttm)4.52
P/S (ttm)2.73
財報日期Aug 27, 2026
賣價66
成交量79,319
20 日平均成交量82,238
開盤價65.61
前收盤價65.22
當日區間63.44 - 65.61
52 週範圍23.47 - 69.86
分析師n/a
目標價n/a
股利n/a
除息日n/a

關於 PDEX

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells ro...

[閱讀更多]
產業 Medical Instruments & Supplies
類股 Healthcare
IPO 日期 Aug 7, 1986
員工 179
證券交易所 NasdaqCM
股票代號 PDEX
網站 https://www.pro-dex.com
完整的公司簡介

財務表現

Pro-Dex 在 2025 年的營收為 66.59M，較前一年的 53.84M 增加 23.68%。 淨利為 8.98M，較前期增加 322.1%。

財務報表

財報驚奇

Pro-Dex 已於 Apr 30, 2026 公布季度財報：
  • 營收為 $19.95M 低於預期 $0, 年增 14.56% 成長.
  • 每股盈餘為 1.2 超出預期 0.58, 年增 96.72% 成長.

下次財報發布

Pro-Dex Inc. 的下次財報預計於 Aug 27, 2026, 收盤後。
分析師預估營收 ... 升級
news image

1 週前 · Zacks

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics (VVOS) delivered earnings and revenue surprises of +26.19% and -5.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

1 週前 · Zacks

Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates

Aveanna (AVAH) delivered earnings and revenue surprises of +29.41% and +3.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

2 週前 · Insider Monkey

Pro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot Commercialization

Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with res...

news image

2 週前 · Zacks

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of +44.44% and +1.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

4 月前 · Simply Wall St.

Is Now The Time To Put Pro-Dex (NASDAQ:PDEX) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

第 1 頁，共 2 頁